Literature DB >> 24024219

Early response to psychological trauma--what GPs can do.

Darryl Wade1, Alexandra Howard, Susan Fletcher, John Cooper, David Forbes.   

Abstract

BACKGROUND: There is a high prevalence of psychological trauma exposure among primary care patients. General practitioners are well placed to provide appropriate support for patients coping with trauma.
OBJECTIVE: This article outlines an evidence-based early response to psychological trauma. DISCUSSION: Psychological first aid is the preferred approach in providing early assistance to patients who have experienced a traumatic event. General practitioners can be guided by five empirically derived principles in their early response: promoting a sense of safety, calming, self efficacy, connectedness and hope. Structured psychological interventions, including psychological debriefing, are not routinely recommended in the first few weeks following trauma exposure. General practitioner self care is an important aspect of providing post-trauma patient care.

Entities:  

Mesh:

Year:  2013        PMID: 24024219

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  3 in total

1.  Skills for Psychological Recovery: Evaluation of a post-disaster mental health training program.

Authors:  Darryl Wade; David Crompton; Alexandra Howard; Naomi Stevens; Olivia Metcalf; Melissa Brymer; Josef Ruzek; Patricia Watson; Richard Bryant; David Forbes
Journal:  Disaster Health       Date:  2015-10-09

2.  A COVID-19 Call to Action: Psychological First Aid Training for Medical Professionals and Trainees.

Authors:  Rachel Zemel
Journal:  Acad Psychiatry       Date:  2022-05-18

3.  Comparing the Role of Aberrant Salience and Dissociation in the Relation between Cumulative Traumatic Life Events and Psychotic-Like Experiences in a Multi-Ethnic Sample.

Authors:  Deidre M Anglin; Adriana Espinosa; Bassem Barada; Rona Tarazi; Ashley Feng; Rachel Tayler; Neil M Allicock; Supriya Pandit
Journal:  J Clin Med       Date:  2019-08-15       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.